undamentalytics Newsletter
Sign in

Viatris cash flow statement

In fiscal 2025, Viatris's operations generated $2.32bn of cash; it spent $379m on capital projects, leaving free cash flow of $1.94bn. It returned $501m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations2,3421,8041,2323,0172,9992,9002,3032,3162,331
Depreciation and amortisation2,1102,0192,2164,5073,0282,7412,8932,7982,804
Stock-based pay−35779111116181146178172
Capital spending252213243457406377326379376
Free cash flow2,0901,5919892,5602,5932,5231,9771,9371,955
Free cash flow after stock pay2,0931,5349102,4492,4772,3421,8311,7591,783
Share buybacks4320000250250501303
Shares issued——0033333

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: HLN vs VTRSUPC vs VTRSBHC vs VTRSVTRS vs ZTS

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Viatris's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Viatris.